Capital Research Global Investors
ARTC

Capital Research Global Investors’s ARTHROCARE CORP ARTC Stock Holding History

Capital Research Global Investors’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,640,725
Closed -$79.1M – 458
2014
Q1 		$79.1M Sell
1,640,725
-768,654
-32% -$36.5M 0.03% 302
2013
Q4 		$97M Buy
2,409,379
+64,329
+3% +$2.38M 0.04% 284
2013
Q3 		$83.4M Buy
2,345,050
+132,675
+6% +$4.63M 0.03% 292
2013
Q2 		$76.4M Buy
+2,212,375
New +$76.1M 0.03% 286

Capital Research Global Investors's ARTC Position: Q2 2014 in Review

Capital Research Global Investors sold out of ARTHROCARE CORP (ARTC) in Q2 2014, closing a stake of 1,640,725 shares — an estimated $79.1M sold.

Capital Research Global Investors first reported a position in ARTC in Q2 2013 and held it in 4 quarters. The position peaked at $97M in Q4 2013. 0 funds tracked by Wall St. Rank hold ARTC as of Q2 2014.

  • Capital Research Global Investors reported no remaining ARTHROCARE CORP position as of Q2 2014 after selling out during the quarter.
  • Capital Research Global Investors sold 1,640,725 ARTHROCARE CORP shares in Q2 2014, an estimated $79.1M.
  • Capital Research Global Investors first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 4 quarters.
  • Capital Research Global Investors's ARTHROCARE CORP position peaked at $97M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q2 2014.

Based on Capital Research Global Investors's 13F filing for Q2 2014, filed 14 Aug 2014.